154 related articles for article (PubMed ID: 3105135)
1. Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response.
Bach JF; Chatenoud L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):17-20. PubMed ID: 3105135
[No Abstract] [Full Text] [Related]
2. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
[No Abstract] [Full Text] [Related]
3. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
4. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies.
Colvin RB; Preffer FI
Clin Lab Med; 1991 Sep; 11(3):693-714. PubMed ID: 1934971
[TBL] [Abstract][Full Text] [Related]
5. In vivo use of OKT3: main issues for the monitoring of treated patients.
Chatenoud L; Ferran C; Bach JF
Transplant Proc; 1990 Dec; 22(6):2605-8. PubMed ID: 2124743
[No Abstract] [Full Text] [Related]
6. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
[No Abstract] [Full Text] [Related]
7. The internal image-like anti-idiotypic response to a CD3-specific monoclonal antibody in primates is dependent on the T cell-binding properties of the injected antibody.
Jonker M; Nooij FJ
Eur J Immunol; 1987 Oct; 17(10):1519-22. PubMed ID: 3500061
[TBL] [Abstract][Full Text] [Related]
8. Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.
Alegre M; Depierreux M; Florquin S; Najdovski T; Vandenabeele P; Abramowicz D; Leo O; Deschodt-Lanckman M; Goldman M
Transplant Proc; 1990 Aug; 22(4):1920-1. PubMed ID: 2143864
[No Abstract] [Full Text] [Related]
9. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.
Chatenoud L; Ferran C; Legendre C; Kurrle R; Kreis H; Bach JF
Transplant Proc; 1990 Aug; 22(4):1787-8. PubMed ID: 2117809
[No Abstract] [Full Text] [Related]
10. Antilymphocytic antibodies and marrow transplantation: ATG suppresses antiantibody formation against monoclonal anti-T-cell antibodies.
Thierfelder S; Kremmer E; Lederer R; Kummer U
Transplant Proc; 1989 Feb; 21(1 Pt 3):3055-7. PubMed ID: 2650423
[No Abstract] [Full Text] [Related]
11. The human immune response to the OKT3 monoclonal antibody is oligoclonal.
Chatenoud L; Jonker M; Villemain F; Goldstein G; Bach JF
Science; 1986 Jun; 232(4756):1406-8. PubMed ID: 3086976
[TBL] [Abstract][Full Text] [Related]
12. Immunologic monitoring in OKT3-treated kidney graft recipients.
Zlabinger GJ; Maurer D; Ulrich W; Meron G; Pohanka E; Kovarik J
Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
[No Abstract] [Full Text] [Related]
13. A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
Norman DJ; Shield CF; Barry J; Henell K; Funnell MB; Lemon J
Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136
[No Abstract] [Full Text] [Related]
14. Suppression of anti-mouse immunoglobulin antibodies in subhuman primates receiving murine monoclonal antibodies against T cell antigens.
Lowder JN; Miller RA; Hoppe R; Levy R
J Immunol; 1987 Jan; 138(2):401-6. PubMed ID: 3540119
[TBL] [Abstract][Full Text] [Related]
15. The human antimouse reaction to OKT3: cross-reactive pattern analysis using a large group of anti-CD3 and isotypic monoclonal antibodies.
Shield CF; Hughes JD; Marlett P; Norman DJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):981-4. PubMed ID: 2523156
[No Abstract] [Full Text] [Related]
16. Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees.
Parleviet KJ; Jonker M; ten Berge RJ; van Lier RA; Wilmink JM; Strengers PF; Aarden LA; Schellekens PT
Transplantation; 1990 Nov; 50(5):889-92. PubMed ID: 2146787
[No Abstract] [Full Text] [Related]
17. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
18. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
Chatenoud L; Baudrihaye MF; Chkoff N; Kreis H; Goldstein G; Bach JF
J Immunol; 1986 Aug; 137(3):830-8. PubMed ID: 3487589
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
[TBL] [Abstract][Full Text] [Related]
20. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties.
Vaessen LM; Kreeftenberg JG; Heyse P; Leerling MF; Baumgartner D; Hendriks GF; Jutte NH; Weimer W
Transplant Proc; 1989 Feb; 21(1 Pt 1):1026-7. PubMed ID: 2523112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
